Piper Sandler launched the coverage of a raft of cancer-focused biotechs with bullish views on Monday while issuing a Neutral recommendation on Summit Therapeutics (NASDAQ:SMMT), citing an unfavorable ...
Arthur J. Gallagher & Co. (NYSE:AJG) is included among 13 Best Long Term Low Risk Stocks to Buy Now. On February 2, Citigroup raised its price objective on Arthur J. Gallagher & Co. (NYSE:AJG) to $280 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results